Stephen Clark

Prof. Stephen Clark

Freeman Hospital, Newcastle upon Tyne, UK
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
DTDavid P. Taggart
David P. Taggart
UBUmberto Benedetto
Umberto Benedetto
SGStephen Gerry
Stephen Gerry
DADouglas G. Altman
Douglas G. Altman
AGAlastair M. Gray
Alastair M. Gray
MFMarcus Flather
Marcus Flather
Multiple arterial grafts may result in longer survival than single arterial grafts after coronary-artery bypass grafting (CABG) surgery. We evaluated the use of bilateral internal-thoracic-artery grafts for CABG.

1 December 2019 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
DRDirk Van Raemdonck
Dirk Van Raemdonck
SKShaf Keshavjee
Shaf Keshavjee
BLBronwyn Levvey
Bronwyn Levvey
WCWida S. Cherikh
Wida S. Cherikh
GSGreg Snell
Greg Snell
MCMarcelo Cypel
Marcelo Cypel

17 July 2017 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
MKMaziar Khorsandi
Maziar Khorsandi
SDScott Dougherty
Scott Dougherty
OBOmar Bouamra
Omar Bouamra
VPVasudev Pai
Vasudev Pai
PCPhilip Curry
Philip Curry
VZVipin Zamvar
Vipin Zamvar
Postcardiotomy cardiogenic shock (PCCS) refractory to inotropic support and intra-aortic balloon pump (IABP) occurs rarely but is almost universally fatal without mechanical circulatory support. In this systematic review and meta-analysis we looked at the evidence behind the use of veno-arterial extra-corporeal membrane oxygenation (VA ECMO) in refractory PCCS from a patient survival rate and determinants of outcome viewpoint. A systematic review was performed in January 2017 using PubMed (with no defined time period) using the keywords “postcardiotomy”, “cardiogenic shock”, “extracorporeal membrane oxygenation” and “cardiac surgery”. We excluded papers pertaining to ECMO following paediatric cardiac surgery, medical causes of cardiogenic shock, as well as case reports, review articles, expert opinions, and letters to the editor. Once the studies were collated, a meta-analysis was performed on the proportion of survivors in those papers that met the inclusion criteria. Meta-regression was performed for the most commonly reported adverse prognostic indicators (API). We identified 24 studies and a cumulative pool of 1926 patients from 1992 to 2016. We tabulated the demographic data, including the strengths and weaknesses for each of the studies, outcomes of VA ECMO for refractory PCCS, complications, and APIs. All the studies were retrospective cohort studies. Meta-analysis of the moderately heterogeneous data (95% CI 0.29 to 0.34, p < 0.01, I 2 = 60%) revealed overall survival rate to hospital discharge of 30.8%. Some of the commonly reported APIs were advanced age (>70 years, 95% CI −0.057 to 0.001, P = 0.058), and long ECMO support (95% CI −0.068 to 0.166, P = 0.412). Postoperative renal failure, high EuroSCORE (>20%), diabetes mellitus, obesity, rising lactate whilst on ECMO, gastrointestinal complications had also been reported. Haemodynamic support with VA ECMO provides a survival benefit with reasonable intermediate and long-term outcomes. Many studies had reported advanced age, renal failure and prolonged VA ECMO support as the most likely APIs for VA ECMO in PCCS. EuroSCORE can be utilized to anticipate the need for prophylactic perioperative VA ECMO in the high-risk category. APIs can be used to aid decision-making regarding both the institution and weaning of ECMO for refractory PCCS.

1 May 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MCMaria M. Crespo
Maria M. Crespo
DMDaniel P. McCarthy
Daniel P. McCarthy
PHPeter M. Hopkins
Peter M. Hopkins
SCStephen Clark
Stephen Clark
MBMarie Budev
Marie Budev
MMMichael Mulligan
Michael Mulligan

1 December 2010 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
ASAnthony De Soyza
Anthony De Soyza
GMGerard Meachery
Gerard Meachery
KHKaty L.M. Hester
Katy L.M. Hester
ANAudrey Nicholson
Audrey Nicholson
GPGareth Parry
Gareth Parry
PCPaul A. Corris
Paul A. Corris

29 October 2015 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
BGBorut Gersak
Borut Gersak
TFTheodor Fischlein
Theodor Fischlein
TFThierry A. Folliguet
Thierry A. Folliguet
BMBart Meuris
Bart Meuris
KTKevin H.T. Teoh
Kevin H.T. Teoh
MGMattia Glauber
Mattia Glauber
OBJECTIVES After a panel process, recommendations on the use of sutureless and rapid deployment valves in aortic valve replacement were given with special respect as an alternative to stented valves. METHODS Thirty-one international experts in both sutureless, rapid deployment valves and stented bioprostheses constituted the panel. After a thorough literature review, evidence-based recommendations were rated in a three-step modified Delphi approach by the experts. RESULTS Literature research could identify 67 clinical trials, 4 guidelines and 10 systematic reviews for detailed text analysis to obtain a total of 28 recommendations. After rating by the experts, 12 recommendations were identified and degree of consensus for each was determined. Proctoring and education are necessary for the introduction of sutureless valves on an institutional basis as well as for the individual training of surgeons. Sutureless and rapid deployment should be considered as the valve prosthesis of first choice for isolated procedures in patients with comorbidities, old age, delicate aortic wall conditions such as calcified root, porcelain aorta or prior implantation of aortic homograft and stentless valves as well as for concomitant procedures and small aortic roots to reduce cross-clamp time. Intraoperative transoesophageal echocardiography is highly recommended, and in case of right anterior thoracotomy, preoperative computer tomography is strongly recommended. Suitable annular sizes are 19–27 mm. There is a contraindication for bicuspid valves only for Type 0 and for annular abscess or destruction due to infective endocarditis. Careful but complete decalcification of the aortic root is recommended to avoid paravalvular leakage; extensive decalcification should be avoided not to create annular defects. Proximal anastomoses of concomitant coronary artery bypass grafting should be placed during a single aortic cross-clamp period or alternatively with careful side clamping. Available evidence suggests that the use of sutureless and rapid deployment valve is associated with (can translate into) reduced early complications such as prolonged ventilation, blood transfusion, atrial fibrillation, pleural effusions and renal replacement therapy, respectively, and may result in reduced intensive care unit and hospital stay in comparison with traditional valves. CONCLUSION The international experts recommend various benefits of sutureless and rapid deployment technology, which may represent a helpful tool in aortic valve replacement for patients requiring a biological valve. However, further evidence will be needed to reaffirm the benefit of sutureless and rapid deployment valves.